Remsima in New Injection Form Shows Safety and Efficacy in Trial
News
A new formulation of CT-P13, a biosimilar of Remicade (infliximab), given as an under-the-skin injection is as safe and effective for people with active Crohn’s disease (CD) and ulcerative colitis (UC) as ... Read more